Detalhe da pesquisa
1.
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and Consensus.
J Assoc Physicians India
; 71(12): 62-74, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38736056
2.
Blood-pressure Lowering Efficacy and Safety of Perindopril / Indapamide / Amlodipine Single-pill Combination in Hypertensive Patients: Phase III Trial in India.
J Assoc Physicians India
; 68(10): 39-43, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32978924
3.
DRESS Syndrome: Drug Rash with Eosinophilia and Systemic Symptoms.
J Assoc Physicians India
; 63(5): 78-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26591154
4.
The LongitudinAl Nationwide stuDy on Management And Real-world outComes of diabetes in India over 3 years (LANDMARC trial).
Endocrinol Diabetes Metab
; 6(5): e422, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392036
5.
Two-year trends from the LANDMARC study: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcome in patients with type 2 diabetes mellitus.
Endocrinol Diabetes Metab
; 6(2): e404, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722454
6.
Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia.
Kidney Int
; 82(11): 1215-22, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22932122
7.
One-year trends from the LANDMARC trial: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcomes of type 2 diabetes mellitus.
Endocrinol Diabetes Metab
; 5(1): e00316, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856077
8.
Baseline characteristics of participants in the LANDMARC trial: A 3-year, pan-india, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitus.
Endocrinol Diabetes Metab
; 4(3): e00231, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34277959
9.
Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study.
Acta Diabetol
; 57(7): 809-818, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030508
10.
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial.
Drugs
; 80(6): 587-600, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162274
11.
Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study.
Am J Cardiovasc Drugs
; 9(3): 135-42, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19463019
12.
Unproven Therapies for Diabetes and Their Implications.
Adv Ther
; 34(1): 60-77, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864668
13.
Comparative clinical trial of S-pantoprazole versus racemic pantoprazole in the treatment of gastro-esophageal reflux disease.
World J Gastroenterol
; 12(37): 6017-20, 2006 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17009401
14.
Critical inclusions in neutrophils-Cryptic and elusive entities.
Indian J Pathol Microbiol
; 64(4): 850-851, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673624
15.
Evaluation Series on Safety and Efficacy of Nutritional Supplements in Newly Diagnosed Hyperglycemia: A Placebo-Controlled, Randomized Study.
N Am J Med Sci
; 8(2): 106-13, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27042609
16.
S-amlodipine--the 2007 clinical review.
J Indian Med Assoc
; 105(4): 180-2, 184, 186 passim, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17822186